Literature DB >> 12857576

Anti-CD20 monoclonal antibody (rituximab) in the treatment of autoimmune diseases. Successful result in refractory Pemphigus vulgaris: report of a case.

Luigi Virgolini1, Vanda Marzocchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12857576

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

1.  Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007.

Authors:  Jennifer D Peterson; Lawrence S Chan
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

Review 2.  Management of Pemphigus Vulgaris.

Authors:  Mimansa Cholera; Nita Chainani-Wu
Journal:  Adv Ther       Date:  2016-06-10       Impact factor: 3.845
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.